CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab to conventional multimodal therapy shows significant benefits in reducing the recurrence risk ...

CHICAGO — Patients who are new users of glucagon-like peptide-1 (GLP-1) receptor agonists have a low absolute risk of thyroid cancer, according to a new study presented at the American Thyroid ...

There are different types of thyroid cancer, which include papillary, follicular, medullary, anaplastic, and oncocytic. Types of thyroid cancer can develop, grow, and spread in different ways, which ...

Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) ...

Genomic landscape and precision therapeutics in follicular thyroid cancer: Insights from the AACR Project GENIE. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

Sally Rohan's decision to go to medical school may have helped save her life. Rohan, 27, is currently undergoing treatment for papillary thyroid cancer, a type of cancer that she said was first ...